首页> 美国卫生研究院文献>Journal of Clinical and Diagnostic Research : JCDR >Nested Multiplex (NMPCR) Detection of Human Papillomavirus (HPV) 16 and 18 in Pre-invasive Lesions and its Implication in Screening of Carcinoma Cervix (CaCx)
【2h】

Nested Multiplex (NMPCR) Detection of Human Papillomavirus (HPV) 16 and 18 in Pre-invasive Lesions and its Implication in Screening of Carcinoma Cervix (CaCx)

机译:侵袭前病变中人乳头瘤病毒(HPV)16和18的巢式多重(NMPCR)检测及其在宫颈癌(CaCx)筛查中的意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Introduction: Carcinoma cervix (CaCx) is a preventable disease and is caused by certain high risk Papillomaviruses. In the present study, our aim was to investigate the utility of Nested Multiplex Polymerase Chain Reaction (NMPCR) in detecting Human Papillomavirus (HPV) 16 and 18 in cervical scrapes/biopsy samples and to correlate with cervical cytology/ histopathology findings.>Methods: A total of 119 females were subjected for Papanicolaou smear examination of cervical scrapes and/or histopathological examination of cervical tissues. These samples were also subjected to nested multiplex PCR targeting HPV 16/ 18 specific E6/7 gene sequences.>Results: HPV 16/18 were detected in 33.6% (40/119) cases included in the study. The overall HPV 16/ 18 positivity among cases with Negative for Intraepithelial Lesion or Malignancy, Low grade Squamous Intraepithelial Lesion, and High grade Squamous Intraepithelial Lesion was observed to be 20.8%, 44%, and 66.7% respectively. Positivity for HPV 16 in cases with Squamous Cell Carcinoma (SCC) was found to be 80%. HPV positivity among subjects reported with reactive cellular changes, a sub category of Negative for Intraepithelial Lesion or Malignancy, was observed to be 26.6%.>Conclusion: HPV 16 and 18 positivity in cases reported with different stages of pre invasive lesions of CaCx, particularly in the subcategory reactive cellular changes of Negative for Intraepithelial Lesion or Malignancy, indicates that NMPCR detection of HPV 16/ 18 may be used as a screening tool for CaCx in conjunction with Papanicolaou smear examination.
机译:>简介:子宫颈癌(CaCx)是一种可预防的疾病,由某些高风险的乳头瘤病毒引起。在本研究中,我们的目的是研究巢式多重聚合酶链反应(NMPCR)在宫颈刮取物/活检样本中检测人乳头瘤病毒(HPV)16和18的实用性,并与宫颈细胞学/组织病理学结果相关联。>方法:共有119名女性接受了宫颈刮片的巴氏涂片检查和/或宫颈组织的组织病理学检查。还对这些样品进行了针对HPV 16/18特异E6 / 7基因序列的巢式多重PCR。>结果:在本研究中33.6%(40/119)的病例中检测到HPV 16/18。上皮内病变或恶性阴性,低度鳞状上皮内病变和高级别鳞状上皮内病变的病例中,HPV 16/18总体阳性率分别为20.8%,44%和66.7%。发现鳞状细胞癌(SCC)患者中HPV 16的阳性率为80%。在报告有反应性细胞变化的受试者中,HPV阳性率为26.6%,是上皮内病变或恶性阴性的一个子类别。>结论:在不同阶段的前期报告的病例中,HPV 16和18阳性CaCx的侵袭性病变,特别是上皮内病变或恶性肿瘤阴性的亚类反应性细胞变化,表明HPPCR 16/18的NMPCR检测可与Papanicolaou涂片检查一起用作CaCx的筛选工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号